Speaker:Bill Morachnick, CEO, Charlotte’s WebDiscussion PointsInterpretation of the Executive Order, and what it actually means for CBDCongress to “update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products”Consultation with appropriate executive departments and agencies and authorities to develop “a regulatory framework for hemp-derived cannabinoid products, including development of guidance on an upper limit on milligrams of THC per serving with considerations on per container limits and CBD to THC ratio requirements”HHS, FDA, CMMS, and NIH to “improve access to hemp-derived cannabinoid products”Reconciling all this with the recent CR (section 781 of Public Law 119-37)How will CBD research be increasedThe EO did not include a call for a formal program in which seniors can rely on Medicare to cover the CBD expenses, if prescribed by a doctor? #CBD #Charlottesweb #cannabis #cannabisindustry #CannabisstocksRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:Mike Gorenstein, CEO, Cronos GroupRick Bakker, CEO, Hollandse HoogtesBastiaan Swager, CEO & Co-Founder, Legacy BrandsVladimir Smetanin, CEO, The GroweryDiscussion PointsThe legal, grey, and illicit markets in HollandSizing up and projecting the pilot marketDemand from outside pilot townsFeedback from consumers and coffeeshop ownersPricing and economics dynamicsAbout the 10 licensed producersPolitical risk#cannabis #cannabisindustry #Netherlands #CronosGroup #Cronos #CannabisstocksRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:Margaret Brodie, CEO, Rubicon OrganicsAdam Coates, Chief Revenue Officer, Decibel CannabisBorna Zlamalik, SVP Innovation & International R&D, Organigram HoldingsDiscussion PointsWhy does vape under index in Canada vs. key US marketsBrands gaining/losing shareWhat are consumers looking forThe continued segment gain of AIOs vs. cartsNew subsgements: live resin; live rosin; liquid diamondsTrends in 510 carts – size sprawl beyond 0.95mlWhy closed-loop systems have not gotten tractionThe recent rollout of vapes in Quebec province#cannabis #cannabisstocks #cannabisdispensary #RubiconOrganics #DecibelCC #OrganigramFollow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speaker:Richard Cheng, Managing Member, Ritter Spencer Cheng PLLCDiscussion PointsHow HB 46 expanded the state’s MMJ market (conditions, formats, access)Caps on flagship stores and satellite pick-up locations per LDO, per regionWho are the new 9 licensees? By when could they be up and runningAbout the next three licenses to be issued in AprilCan the three incumbents sell their licenses? and the new awardees?Impact from new hemp rules#cannabis #cannabisstocks #cannabisdispensary #Ritter_Spencer#Trulieve #Verano #FluentCannabis #SNDL #TexasCannabis #cannabislawRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:Jon Levine, CEO, MariMedAnthony Coniglio, CEO, NewLake Capital PartnersJim Cacioppo, CEO, Jushi Holdings Discussion PointsWith MSO stocks back at historical lows, what are investors getting wrong?Quantifying the upside for the regulated cannabis operators from the ban on hemp derivatives, on sales as well as on pricingThe potential for a pardon of 280e tax liabilities, or at least for a partial pardon and long-term payment agreementsThe potential for phasing out 280e even without reschedulingThe timing, process, and structure of rescheduling; and the benefits beyond taxesDescheduling vs. reschedulingThe Supreme Court angle and the recent Koch Brothers amicus brief filed with the courtState level catalysts (there are several)#CannabisIndustry #CannabisInvesting #MSOs #280E #CannabisRescheduling #CannabisStocks #HempTHC #CannabisRegulation #MariMed #NLCP #JushiFollow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcThis video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speaker:Irwin Simon. Chairman & CEO, Tilray BrandsDiscussion PointsImpact from spending bill (CR) on HDD9 drinks strategyContinued progress improvement in the beer and liquor businessOutlook for the international medical cannabis business (MMJ)State of Tilray’s position in Canada’s rec marketBalance sheet strength and cash deployment plansA cannabis company or a CPG company?How TLRY can benefit from being the most liquid cannabis stock in NASDAQ?#cannabis #cannabisstocks #cannabisdispensary #Tilray #IrwinDSimonRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:Amber Shimpa, President, Vireo GrowthZachery Wilson, CEO, Waabigwan MashkikiTim Gordon, Founder/CEO, Gordon CannabisJason Tarasek, Partner, Vicente LLPDiscussion PointsStart of rec in mid September, or just a soft launch? Market momentum?Rec market limitations on the two medical incumbents (Vireo Growth and Green Thumb)The role of the Tribal Nations in the MN cannabis marketTiming for new rec licensees to get up and running (dispensaries, growers, other), and numbersThe hemp derivatives angle and potential regulatory changes#cannabis #cannabisstocks #cannabisdispensary #VireoGrowth #VicenteLLP #GordonCannabis #WaabigwanMashkikiRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:Trent Woloveck, Chief Strategy Director, Jushi HoldingsJared Maloof, CEO, Standard WellnessEdward Schmults, CEO, Firelands ScientificDiscussion PointsIs growth stalling? deflation creeping in?Pace of new store openings? not near saturation?Waiting for AU regsRollout of pre-rollsImpact from hemp derivatives market#cannabis #cannabisstocks #cannabisdispensary #Jushiholdings #StandardWellnessCo #FirelandsScientificRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:Adam Coates, Chief Revenue Officer, Decibel CannabisScott Lough, VP Product Management & Marketing, Canopy GrowthBradley Gunter, SVP of Sales, Organigram HoldingsDiscussion PointsHow pre-rolls became the largest category in Canada, overtaking flowerLeading brands and latest innovationThe rise of infused pre-rolls, and new entrantsJoints vs. blunts; variety packsShopper behaviorQuebec rolling out pre-rolls#cannabis #cannabisstocks #cannabisdispensary #DecibelCannabis #Organigram #CanopyGrowthRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speaker:Robert Groesbeck, Co-CEO, Planet 13 HoldingsDaniel Firtel, President, TRP Co/ Cookies FloridaAaron Bloom, CEO, DocMJ ClinicsDiscussion points:Operators’ strategies in FLRoom to increase “store rev yield”State of the FL market (more stores and capacity?)Pricing climateHemp competition, and new rulesNov 26 ballot?#cannabis #cannabisstocks #cannabisdispensary #Planet 13 #TRPCo #cookiesFL #DOCMJRenowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.Follow us on http://[email protected] inX https://x.com/420Odysseushttps://www.linkedin.com/company/zuanic-associates-llcDisclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.